• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液传播组织因子的病理生理学作用:是否应重新审视旧模式?

Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?

机构信息

Atherothrombosis Research Unit, Mount Sinai Hospital, New York, NY, USA.

出版信息

Intern Emerg Med. 2011 Feb;6(1):29-34. doi: 10.1007/s11739-010-0423-4. Epub 2010 Jul 7.

DOI:10.1007/s11739-010-0423-4
PMID:20607451
Abstract

The term "vulnerable plaque" identifies atherosclerotic lesions prone to rupture. Plaque disruption facilitates the interaction of the inner components of the lesion, tissue factor (TF) among them, with the flowing blood. This results in activation of the coagulation cascade, ultimately leading to thrombus formation, and abrupt vascular occlusion. Despite the central role of vulnerable plaques in the onset of acute coronary syndromes (ACS), there are certain conditions (e.g., eroded plaques) where a hyperactive, "vulnerable" blood, may play a predominant pathophysiological role. Recently, two distinct pools of circulating TF have been identified. One, associated with cell-derived microparticles probably originating from apoptotic cells, such as macrophages, smooth muscle cells, and endothelium. The most recent, blood-borne TF, circulates in an "inactive" form (encryption) and has to be activated (decryption) to exert its thrombogenic activity. Certain pathological conditions associated with an increased rate of thrombotic complications have been associated with high levels of circulating TF. It is thought that the blood-borne TF perpetuates the initial thrombogenic stimulus, leading to the formation of larger or more stable thrombus, and thus, more severe ACS. Thus, the concept of vulnerable blood could represent a new link between the vulnerable lesion and the high-risk patient. Therefore, the assessment of selected biomarkers associated with "vulnerable or hyperreactive blood", e.g., blood-borne tissue factor, may represent a useful tool to identify patients with a high-risk profile of developing major cardiovascular events.

摘要

“易损斑块”一词指的是易于破裂的动脉粥样硬化斑块。斑块破裂使病变的内部成分(包括组织因子 TF)与流动的血液相互作用。这导致凝血级联反应的激活,最终导致血栓形成和血管突然阻塞。尽管易损斑块在急性冠脉综合征(ACS)的发病中起着核心作用,但在某些情况下(如侵蚀性斑块),活性过高的“易损”血液可能发挥主要的病理生理作用。最近,已经确定了两种不同的循环 TF 池。一种与源自细胞的细胞衍生微粒体(如巨噬细胞、平滑肌细胞和内皮细胞)相关。最新的血液来源 TF 以“非活性”形式(加密)循环,必须被激活(解密)才能发挥其促血栓形成活性。某些与血栓形成并发症发生率增加相关的病理状况与循环 TF 水平升高有关。人们认为,血液来源的 TF 使最初的促血栓形成刺激持续存在,导致形成更大或更稳定的血栓,从而导致更严重的 ACS。因此,易损血液的概念可能代表易损病变与高危患者之间的新联系。因此,评估与“易损或高反应性血液”相关的选定生物标志物,如血液来源的组织因子,可能是识别发生主要心血管事件风险较高的患者的有用工具。

相似文献

1
Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?血液传播组织因子的病理生理学作用:是否应重新审视旧模式?
Intern Emerg Med. 2011 Feb;6(1):29-34. doi: 10.1007/s11739-010-0423-4. Epub 2010 Jul 7.
2
The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?动脉粥样硬化、炎症与血栓形成之间缺失的环节:是组织因子吗?
Expert Rev Cardiovasc Ther. 2011 Apr;9(4):517-23. doi: 10.1586/erc.11.40.
3
Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation.动脉粥样硬化血栓形成:组织因子的作用;糖尿病、肥胖与炎症之间的联系。
Indian J Exp Biol. 2007 Jan;45(1):103-10.
4
Role of Tissue Factor in the Coagulation Network.组织因子在凝血网络中的作用。
Semin Thromb Hemost. 2015 Oct;41(7):708-17. doi: 10.1055/s-0035-1564045. Epub 2015 Sep 26.
5
Tissue factor and atherothrombosis.组织因子与动脉粥样硬化血栓形成
Curr Pharm Des. 2015;21(9):1152-7. doi: 10.2174/1381612820666141013154946.
6
Microparticles as new markers of cardiovascular risk in diabetes and beyond.微粒作为糖尿病及其他心血管风险的新标志物。
Thromb Haemost. 2016 Aug 1;116(2):220-34. doi: 10.1160/TH16-03-0176. Epub 2016 May 12.
7
Links between inflammation and thrombogenicity in atherosclerosis.动脉粥样硬化中炎症与血栓形成倾向之间的联系。
Curr Mol Med. 2006 Aug;6(5):489-99. doi: 10.2174/156652406778018707.
8
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.
Blood. 2002 Apr 15;99(8):2794-800. doi: 10.1182/blood.v99.8.2794.
9
Apoptosis as a determinant of atherothrombosis.细胞凋亡作为动脉粥样硬化血栓形成的一个决定因素。
Thromb Haemost. 2001 Jul;86(1):420-6.
10
[Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes].
Rev Esp Cardiol. 2003 Oct;56(10):1001-9. doi: 10.1016/s0300-8932(03)76998-x.

引用本文的文献

1
Extracellular Vesicles: A Double-Edged Sword in Sepsis.细胞外囊泡:脓毒症中的双刃剑
Pharmaceuticals (Basel). 2021 Aug 23;14(8):829. doi: 10.3390/ph14080829.
2
Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes.血小板 P 选择素触发单核细胞中组织因子的快速表面暴露。
Sci Rep. 2019 Sep 16;9(1):13397. doi: 10.1038/s41598-019-49635-7.
3
Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.组织因子:血栓形成中的新概念及其在血栓形成和止血之外的作用。

本文引用的文献

1
The biological significance of the thromboplastic protein of blood.血液促凝血蛋白的生物学意义。
J Biol Chem. 1946 Nov;166(1):189-97.
2
Microparticles and thrombotic disease.微粒与血栓形成性疾病
Curr Opin Hematol. 2009 Sep;16(5):334-41. doi: 10.1097/MOH.0b013e32832ea49c.
3
Tissue factor in coagulation: Which? Where? When?凝血中的组织因子:哪一种?何处?何时?
Cardiovasc Diagn Ther. 2018 Oct;8(5):581-593. doi: 10.21037/cdt.2018.10.14.
4
Thrombosis in Cerebral Aneurysms and the Computational Modeling Thereof: A Review.脑动脉瘤中的血栓形成及其计算模型综述
Front Physiol. 2018 Apr 4;9:306. doi: 10.3389/fphys.2018.00306. eCollection 2018.
5
Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease.血小板-中性粒细胞相互作用作为炎症和血栓性疾病的驱动因素。
Cell Tissue Res. 2018 Mar;371(3):567-576. doi: 10.1007/s00441-017-2727-4. Epub 2017 Nov 25.
6
Immune-Inflammatory Activation in Acute Coronary Syndromes: A Look into the Heart of Unstable Coronary Plaque.急性冠状动脉综合征中的免疫炎症激活:深入不稳定冠状动脉斑块的核心
Curr Cardiol Rev. 2017;13(2):110-117. doi: 10.2174/1573403X12666161014093812.
7
High intravascular tissue factor-but not extracellular microvesicles-in septic patients is associated with a high SAPS II score.脓毒症患者血管内组织因子水平高(而非细胞外微小囊泡)与 SAPS II 评分高相关。
J Intensive Care. 2016 May 23;4:34. doi: 10.1186/s40560-016-0160-5. eCollection 2016.
8
A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes.促凝微囊在早期宿主防御化脓性链球菌中的新作用。
PLoS Pathog. 2013;9(8):e1003529. doi: 10.1371/journal.ppat.1003529. Epub 2013 Aug 1.
9
Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.硫氧还蛋白和硫氧还蛋白还原酶通过巯基氧化还原依赖的机制控制组织因子活性。
J Biol Chem. 2013 Feb 1;288(5):3346-58. doi: 10.1074/jbc.M112.418046. Epub 2012 Dec 7.
10
Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats.人 C 反应蛋白加重生物繁育糖尿病大鼠中巨噬细胞的活性。
J Diabetes Complications. 2013 Jan-Feb;27(1):23-8. doi: 10.1016/j.jdiacomp.2012.03.020. Epub 2012 Apr 18.
Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):1989-96. doi: 10.1161/ATVBAHA.108.177402. Epub 2009 Jul 10.
4
Cell-derived microparticles in haemostasis and vascular medicine.止血与血管医学中的细胞衍生微粒
Thromb Haemost. 2009 Mar;101(3):439-51.
5
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.体外炎症条件下心肌细胞全长组织因子表达及微粒释放的调控
J Thromb Haemost. 2009 May;7(5):871-8. doi: 10.1111/j.1538-7836.2009.03323.x. Epub 2009 Feb 18.
6
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay.冠状动脉疾病患者血浆组织因子活性的评估:一种商业检测方法的局限性
J Thromb Haemost. 2009 May;7(5):894-7. doi: 10.1111/j.1538-7836.2009.03315.x. Epub 2009 Feb 12.
7
Circulating tissue factor-exposing microparticles.循环中暴露组织因子的微粒。
Thromb Res. 2008;122 Suppl 1:S47-54. doi: 10.1016/S0049-3848(08)70019-7.
8
No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils.在免疫分离的高纯度嗜酸性粒细胞制剂中,没有证据表明存在组织因子。
J Thromb Haemost. 2008 Oct;6(10):1742-9. doi: 10.1111/j.1538-7836.2008.03105.x. Epub 2008 Jul 28.
9
Factor XIa and tissue factor activity in patients with coronary artery disease.冠心病患者中的凝血因子Ⅺa和组织因子活性。
Thromb Haemost. 2008 Jan;99(1):142-9. doi: 10.1160/TH07-08-0499.
10
Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.可变剪接的人组织因子在胰腺癌肿瘤模型中促进肿瘤生长和血管生成。
Thromb Res. 2007;120 Suppl 2:S13-21. doi: 10.1016/S0049-3848(07)70126-3.